Proteostasis Therapeutics and CF Europe Announce Completion of Patient Enrollment for CHOICES, the First-Ever Personalized Medicine-Based Study in Cystic Fibrosis

Stock Information for Proteostasis Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.